Cargando…
High cell density perfusion process for high yield of influenza A virus production using MDCK suspension cells
ABSTRACT: Similar to the recent COVID-19 pandemic, influenza A virus poses a constant threat to the global community. For the treatment of flu disease, both antivirals and vaccines are available with vaccines the most effective and safest approach. In order to overcome limitations in egg-based vacci...
Autores principales: | Wu, Yixiao, Bissinger, Thomas, Genzel, Yvonne, Liu, Xuping, Reichl, Udo, Tan, Wen-Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847233/ https://www.ncbi.nlm.nih.gov/pubmed/33515287 http://dx.doi.org/10.1007/s00253-020-11050-8 |
Ejemplares similares
-
Tracking changes in adaptation to suspension growth for MDCK cells: cell growth correlates with levels of metabolites, enzymes and proteins
por: Pech, Sabine, et al.
Publicado: (2021) -
MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation
por: Genzel, Yvonne, et al.
Publicado: (2010) -
Process intensification of EB66® cell cultivations leads to high-yield yellow fever and Zika virus production
por: Nikolay, Alexander, et al.
Publicado: (2018) -
High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system
por: Vázquez-Ramírez, Daniel, et al.
Publicado: (2019) -
Production of retroviral vectors in continuous high cell density culture
por: Hein, Marc D., et al.
Publicado: (2023)